Increased PSMA-Targeted 18 F-DCFPyL Uptake in Peripheral T-Cell Lymphoma
- PMID: 38739487
- DOI: 10.1097/RLU.0000000000005264
Increased PSMA-Targeted 18 F-DCFPyL Uptake in Peripheral T-Cell Lymphoma
Abstract
Peripheral T-cell lymphomas are a heterogenous group of lymphomas with a high rate of extranodal disease. We present a case of increased 18 F-DCFPyL uptake in peripheral T-cell lymphoma of subcutaneous tissue and bone. Familiarity with the increased 18 F-DCFPyL uptake and extranodal presentation of peripheral T-cell lymphomas can avoid misinterpretation for metastatic disease.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest and sources of funding: A.M. reports consultancy for Bristol Myers Squibb. The rest of the authors have no conflicts of interest declared.
References
-
- Weisenburger DD, Savage KJ, Harris NL, et al. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the international peripheral T-cell lymphoma project. Blood . 2011;117:3402–3408.
-
- Hofman MS, Lawrentschuk N, Francis RJ, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet . 2020;395:1208–1216.
-
- Wondergem M, van der Zant FM, Broos WAM, et al. Matched-pair comparison of 18 F-DCFPyL PET/CT and 18 F-PSMA-1007 PET/CT in 240 prostate cancer patients: interreader agreement and lesion detection rate of suspected lesions. J Nucl Med . 2021;62:1422–1429.
-
- Caputo SA, Jang A, Talbert J, et al. Prostate-specific membrane antigen PET positivity in a lung mass: diagnosis of diffuse large B-cell lymphoma. Clin Nucl Med . 2023;48:190–191.
-
- Dendl K, Merkel A, Kratochwil C, et al. Positive multifocal PSMA PET/CT in a patient with prostate cancer and follicular lymphoma. Clin Nucl Med . 2022;47:e47–e48.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous